Literature DB >> 21298299

Extranigral extension of structural midbrain lesions overshadows parkinsonism.

Hee Jin Kim1, Ji Young Yun, Jong-Min Kim, Yu Kyeong Kim, Gwanhee Erm, Sang Eun Kim, Beom S Jeon.   

Abstract

We report on a clinicoanatomical analysis of five patients with structural midbrain lesions who shared severe nigrostriatal dopaminergic denervation but presented different involuntary movements. The main clinical phenotype was parkinsonism in only one case; it was choreoballism in three cases and tremor and dystonia in one case. Structural midbrain lesions are likely to involve structures additional to nigral dopaminergic neurons. The extent of extranigral involvement may determine the diverse clinical manifestations associated with the structural midbrain lesions.

Entities:  

Mesh:

Year:  2011        PMID: 21298299     DOI: 10.1007/s00702-011-0584-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  13 in total

1.  Hemi-parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging.

Authors:  S Goldstein; J H Friedman; R Innis; J Seibyl; K Marek
Journal:  Mov Disord       Date:  2001-03       Impact factor: 10.338

2.  Hemiballism after subthalamotomy in patients with Parkinson's disease: report of 2 cases.

Authors:  Chiung-Chu Chen; Shih-Tseng Lee; Tony Wu; Chi-Jen Chen; Chin-Chang Huang; Chin-Song Lu
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

3.  Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.

Authors:  Evzen Růzicka; Dusan Urgosík; Robert Jech; Jan Roth; Josef Vymazal; Petr Mecír; Vilibald Vladyka
Journal:  Mov Disord       Date:  2005-06       Impact factor: 10.338

4.  Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.

Authors:  M Vidailhet; C Dupel; S Lehéricy; P Remy; D Dormont; M Serdaru; P Jedynak; H Veber; Y Samson; C Marsault; Y Agid
Journal:  Arch Neurol       Date:  1999-08

5.  Hemiparkinsonism associated with a mesencephalic tumor.

Authors:  M Yoshimura; T Yamamoto; N Iso-o; I Imafuku; T Momose; I Shirouzu; S Kwak; I Kanazawa
Journal:  J Neurol Sci       Date:  2002-05-15       Impact factor: 3.181

6.  Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine.

Authors:  M Merello; S Perez-Lloret; J Antico; J A Obeso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT.

Authors:  J S Kim; K S Lee; K H Lee; Y I Kim; B S Kim; Y A Chung; S K Chung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 8.  Vascular Parkinsonism: a case report and review of the literature.

Authors:  S Peters; E G Eising; H Przuntek; T Müller
Journal:  J Clin Neurosci       Date:  2001-05       Impact factor: 1.961

9.  Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.

Authors:  H Boecker; A Weindl; K Leenders; A Antonini; T Kuwert; F Kruggel; H Grafin von Einsiedel; B Conrad
Journal:  Acta Neurol Scand       Date:  1996-06       Impact factor: 3.209

10.  Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.

Authors:  K L Leenders; R S Frackowiak; N Quinn; D Brooks; D Sumner; C D Marsden
Journal:  Mov Disord       Date:  1986       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.